Dr. Amit Mahipal, MD
Claim this profileMayo Clinic
Studies Tumors
Studies Bile Duct Cancer
19 reported clinical trials
36 drugs studied
About Amit Mahipal, MD
Education:
- Obtained MD from Maulana Azad Medical College, India, in 2003.
- Completed Residency in Internal Medicine at the University of Connecticut Health Center (2005-2008).
- Undertook Fellowship in Hematology/Oncology at Thomas Jefferson University Hospital (2008-2011).
Experience:
- Specializes in Hematology and Oncology.
- Affiliated with University Hospitals in Cleveland and Beachwood, Ohio.
- Certified by the American Board of Internal Medicine in Hematology and Medical Oncology.
Area of expertise
1Tumors
Stage IV
Stage III
MMR positive
2Bile Duct Cancer
Stage IV
FGFR2 positive
IDH positive
Affiliated Hospitals
Clinical Trials Amit Mahipal, MD is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting1 award Phase 23 criteria
Olaparib
for Biliary Tract Cancer
This trial studies how well olaparib works in patients with advanced biliary tract cancer and specific DNA repair gene mutations. Olaparib may help stop cancer growth by blocking enzymes needed for cell repair. The trial aims to see if this treatment can improve survival and response rates.
Recruiting1 award Phase 222 criteria
More about Amit Mahipal, MD
Clinical Trial Related2 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Amit Mahipal, MD has experience with
- Cisplatin
- Gemcitabine
- ELU001
- Tucatinib
- Trastuzumab
- Fulvestrant
Breakdown of trials Amit Mahipal, MD has run
Tumors
Bile Duct Cancer
Cancer
Biliary Tract Cancer
Cholangiocarcinoma
- Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer
- Chemotherapy + Targeted Therapy for Bile Duct Cancer
- A Study of ABC294640 (Yeliva ®) Alone and in Combination With Hydroxychloroquine Sulfate in Treatment of Patients With Advanced Cholangiocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amit Mahipal, MD specialize in?
Amit Mahipal, MD focuses on Tumors and Bile Duct Cancer. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is Amit Mahipal, MD currently recruiting for clinical trials?
Yes, Amit Mahipal, MD is currently recruiting for 6 clinical trials in Rochester Minnesota. If you're interested in participating, you should apply.
Are there any treatments that Amit Mahipal, MD has studied deeply?
Yes, Amit Mahipal, MD has studied treatments such as Cisplatin, Gemcitabine, ELU001.
What is the best way to schedule an appointment with Amit Mahipal, MD?
Apply for one of the trials that Amit Mahipal, MD is conducting.
What is the office address of Amit Mahipal, MD?
The office of Amit Mahipal, MD is located at: Mayo Clinic, Rochester, Minnesota 55905 United States. This is the address for their practice at the Mayo Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.